Shenzhen New Industries Biomedical Engineering Co.,Ltd. (SZSE: 300832) has announced a plan to repurchase a portion of its publicly held shares using its own capital through centralized competitive bidding. The repurchased shares are intended for use in an employee stock ownership plan or for equity incentives. The repurchase price per share will not exceed 60 yuan, inclusive. The total amount of funds allocated for the repurchase is set to be no less than 1 billion yuan and no more than 2 billion yuan, both amounts inclusive.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments